论文部分内容阅读
多发性骨髓瘤(MM)是一种起源于B细胞系并能够产生单克隆免疫球蛋白的恶性增生性疾病。我国骨髓瘤发病率为1/10万,约占恶性肿瘤的1%,发病年龄大都在50~60岁之间。MM尚无根治的方法。现对MM的联合治疗、干细胞移植、新型药物治疗及并发症的治疗进行论述。
Multiple myeloma (MM) is a malignant proliferative disease that originates in the B cell line and is capable of producing monoclonal immunoglobulins. Myeloma incidence of 1/10 million, accounting for about 1% of malignant tumors, most of the onset age between 50 to 60 years old. MM still no cure. Now MM combined treatment, stem cell transplantation, new drug treatment and treatment of complications are discussed.